Table 1.
Patient Characteristics
| Characteristic | Total (N=31) N (%) |
|---|---|
| Sex, Male | 17 (54.8) |
| Age, median (IQR), years | 66 (56, 70) |
| Race | |
| Caucasian | 31 (100) |
| Cardiovascular comorbidities | |
| Cardiac arrhythmia | 8 (25.8) |
| Cardiomyopathy | 1 (3.2) |
| Coronary artery disease | 5 (16.1) |
| Hypertension | 7 (22.6) |
| Dyslipidemia | 3 (9.7) |
| Indication | |
| Pulmonary | 16 (51.6) |
| Disseminated | 12 (38.7) |
| Tenosynovitis | 2 (6.5) |
| Prophylaxis | 1 (3.2) |
| Organism | |
| Histoplasma | 15 (48.4) |
| Aspergillus | 2 (6.5) |
| Coccidioides | 3 (9.7) |
| Blastomyces | 5 (16.1) |
| Prophylaxis | 1 (3.2) |
| Cryptococcus | 1 (3.2) |
| Other Fungal NOS | 4 (12.9) |
| Naranjo Score, median (range) points | 7 (5-9) |
IQR = interquartile range; NOS = not otherwise specified.